Osler Diagnostics
A ground-breaking handheld diagnostic for testing a vast range of biomarkers.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | £74.2m | Series C | |
| Total Funding | 000k | ||
| GBP | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | (43 %) | (16 %) | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | (1993 %) | (5583 %) | (8044 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | (1784 %) | (5189 %) | (6962 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Osler Diagnostics is a healthcare technology startup that aims to revolutionize global healthcare through its innovative product, the Osler Origin®. This device offers a wide range of tests that can be used in various healthcare settings such as emergency departments, doctor's offices, and retail pharmacies. The company's unique selling proposition lies in its proprietary "lab-in-your-hand" technology, which includes the Osler HemaTap® for sample addition, microfluidic sample preparation, and electrochemical biosensing.
The technology behind Osler Origin® is the result of extensive research at Oxford University, followed by years of industrialization by Osler. The company has a robust intellectual property portfolio that protects its unique technology.
Osler Diagnostics operates in the healthcare technology market, serving healthcare providers across different settings. Its business model revolves around the sale of its Osler Origin® device and the tests it offers. The company generates revenue from the sale of these devices and tests to healthcare providers.
The team behind Osler Diagnostics is led by Co-Founder and CEO, Connor Campbell, who has a background in medical sciences and business consultancy. The commercial strategy is overseen by Chief Commercial Officer, Tom Parenteau, who brings over 25 years of experience in global marketing and sales in the healthcare sector.
Keywords: Healthcare Technology, Osler Origin®, Lab-in-your-hand Technology, Osler HemaTap®, Microfluidic Sample Preparation, Electrochemical Biosensing, Oxford University Research, Intellectual Property, Medical Testing, Healthcare Providers.